Sarcopenia in male patients with head and neck cancer receiving chemoradiotherapy: a longitudinal pilot study.

ABSTRACT:

Introduction

Muscle wasting conditions such as sarcopenia may be highly prevalent in advanced head and neck cancer (HNC) patients (16-71%), with these prevalence rates substantially greater in those who have received chemo-radiotherapy (CRT). According to the updated European Working Group on Sarcopenia in Older People consensus statement, sarcopenia is defined as the age-related loss of muscle strength, muscle mass and physical performance. The high prevalence of sarcopenia in HNC patients is concerning as it has been associated with substantially increased risk of CRT toxicity, respiratory complications and early mortality. With the high prevalence of HNC and sarcopenia in India and the strong link between sarcopenia and poor HNC patient outcomes, it is important to screen for th

SUBMITTER: Chauhan NS 

PROVIDER: S-EPMC7049254 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature